Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Non-interventional, Observational Study in Patients With IBD Receiving IV or SC Vedolizumab Therapy to Observe Route of Administration Choices and Outcomes (VARIETY-AUT)

NCT04890262 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT04890262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04890262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Non-interventional, Observational Study in Patients With IBD Receiving IV or SC Vedolizumab Therapy to Observe Route of Administration Choices and Outcomes (VARIETY-AUT)
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
August 18, 2021
Completion date
June 30, 2024
Enrollment
99 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

colitis, ulcerative, crohns disease, inflammatory bowel diseases